Twist Net Debt vs Retained Earnings Analysis

TWST Stock

USD 43.09 0.95 2.16%

Twist Bioscience financial indicator trend analysis is much more than just breaking down Twist Bioscience Corp prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Twist Bioscience Corp is a good investment. Please check the relationship between Twist Bioscience Net Debt and its Retained Earnings accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Twist Bioscience Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

Net Debt vs Retained Earnings

Net Debt vs Retained Earnings Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Twist Bioscience Corp Net Debt account and Retained Earnings. At this time, the significance of the direction appears to have strong relationship.

The correlation between Twist Bioscience's Net Debt and Retained Earnings is 0.76. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Retained Earnings in the same time period over historical financial statements of Twist Bioscience Corp, assuming nothing else is changed. The correlation between historical values of Twist Bioscience's Net Debt and Retained Earnings is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of Twist Bioscience Corp are associated (or correlated) with its Retained Earnings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Retained Earnings has no effect on the direction of Net Debt i.e., Twist Bioscience's Net Debt and Retained Earnings go up and down completely randomly.

Correlation Coefficient

0.76

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Most indicators from Twist Bioscience's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Twist Bioscience Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Twist Bioscience Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

At this time, Twist Bioscience's Tax Provision is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 1.19 in 2024, whereas Selling General Administrative is likely to drop slightly above 109.9 M in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	333.3M	296.6M	341.1M	170.8M
Cost Of Revenue	119.3M	155.4M	178.7M	187.6M

Total Operating Expenses Cost Of Revenue

Twist Bioscience fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Shares Outstanding	Short Term Investments	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Inventory
Total Assets		0.9	0.7	0.99	0.94	0.27	0.91	0.89	0.65	-0.85	-0.93	0.94	0.93	0.87	0.83	0.26	-0.88	0.96	0.9	0.83	0.98	0.39	-0.75	-0.53	0.92	0.94
Short Long Term Debt Total	0.9		0.59	0.89	0.96	0.11	0.98	1.0	0.8	-0.76	-0.96	0.83	0.82	0.99	0.75	0.09	-0.84	0.84	0.98	0.97	0.9	0.32	-0.72	-0.45	0.98	0.97
Other Current Liab	0.7	0.59		0.7	0.64	0.02	0.57	0.62	0.05	-0.62	-0.56	0.72	0.64	0.61	0.32	0.01	-0.51	0.7	0.53	0.59	0.56	0.4	-0.41	-0.23	0.57	0.66
Total Current Liabilities	0.99	0.89	0.7		0.93	0.24	0.91	0.89	0.65	-0.84	-0.94	0.97	0.92	0.88	0.85	0.24	-0.89	0.95	0.9	0.84	0.98	0.4	-0.75	-0.54	0.92	0.94
Total Stockholder Equity	0.94	0.96	0.64	0.93		0.24	0.99	0.95	0.77	-0.82	-0.96	0.88	0.87	0.93	0.77	0.22	-0.93	0.93	0.97	0.89	0.92	0.48	-0.87	-0.65	0.99	0.98
Other Liab	0.27	0.11	0.02	0.24	0.24		0.15	0.03	0.22	-0.67	-0.13	0.29	0.57	0.0	0.43	1.0	-0.29	0.45	0.11	-0.08	0.23	-0.21	-0.23	-0.21	0.16	0.26
Net Tangible Assets	0.91	0.98	0.57	0.91	0.99	0.15		0.97	0.82	-0.76	-0.97	0.85	0.82	0.96	0.77	0.14	-0.91	0.88	0.99	0.93	0.92	0.44	-0.84	-0.61	1.0	0.97
Property Plant And Equipment Net	0.89	1.0	0.62	0.89	0.95	0.03	0.97		0.78	-0.72	-0.96	0.83	0.79	1.0	0.73	0.02	-0.83	0.81	0.97	0.99	0.89	0.33	-0.71	-0.44	0.98	0.96
Current Deferred Revenue	0.65	0.8	0.05	0.65	0.77	0.22	0.82	0.78		-0.56	-0.83	0.59	0.61	0.77	0.79	0.22	-0.78	0.61	0.85	0.75	0.75	0.19	-0.66	-0.49	0.84	0.77
Net Debt	-0.85	-0.76	-0.62	-0.84	-0.82	-0.67	-0.76	-0.72	-0.56		0.76	-0.87	-0.97	-0.7	-0.8	-0.66	0.78	-0.92	-0.73	-0.64	-0.79	-0.12	0.61	0.4	-0.77	-0.87
Retained Earnings	-0.93	-0.96	-0.56	-0.94	-0.96	-0.13	-0.97	-0.96	-0.83	0.76		-0.88	-0.83	-0.95	-0.85	-0.13	0.92	-0.87	-0.98	-0.92	-0.95	-0.39	0.76	0.52	-0.98	-0.96
Accounts Payable	0.94	0.83	0.72	0.97	0.88	0.29	0.85	0.83	0.59	-0.87	-0.88		0.92	0.83	0.86	0.31	-0.86	0.92	0.84	0.79	0.91	0.29	-0.67	-0.45	0.87	0.92
Cash	0.93	0.82	0.64	0.92	0.87	0.57	0.82	0.79	0.61	-0.97	-0.83	0.92		0.77	0.85	0.55	-0.81	0.95	0.8	0.72	0.89	0.17	-0.65	-0.43	0.83	0.91
Non Current Assets Total	0.87	0.99	0.61	0.88	0.93	0.0	0.96	1.0	0.77	-0.7	-0.95	0.83	0.77		0.72	-0.02	-0.8	0.79	0.96	0.99	0.87	0.29	-0.68	-0.41	0.96	0.95
Non Currrent Assets Other	0.83	0.75	0.32	0.85	0.77	0.43	0.77	0.73	0.79	-0.8	-0.85	0.86	0.85	0.72		0.45	-0.85	0.81	0.8	0.68	0.9	0.13	-0.56	-0.36	0.8	0.83
Other Assets	0.26	0.09	0.01	0.24	0.22	1.0	0.14	0.02	0.22	-0.66	-0.13	0.31	0.55	-0.02	0.45		-0.3	0.44	0.11	-0.09	0.23	-0.2	-0.22	-0.2	0.15	0.26
Long Term Debt	-0.88	-0.84	-0.51	-0.89	-0.93	-0.29	-0.91	-0.83	-0.78	0.78	0.92	-0.86	-0.81	-0.8	-0.85	-0.3		-0.91	-0.93	-0.74	-0.91	-0.58	0.82	0.64	-0.92	-0.9
Cash And Short Term Investments	0.96	0.84	0.7	0.95	0.93	0.45	0.88	0.81	0.61	-0.92	-0.87	0.92	0.95	0.79	0.81	0.44	-0.91		0.86	0.72	0.93	0.45	-0.78	-0.59	0.88	0.92
Net Receivables	0.9	0.98	0.53	0.9	0.97	0.11	0.99	0.97	0.85	-0.73	-0.98	0.84	0.8	0.96	0.8	0.11	-0.93	0.86		0.93	0.92	0.45	-0.78	-0.54	0.99	0.97
Good Will	0.83	0.97	0.59	0.84	0.89	-0.08	0.93	0.99	0.75	-0.64	-0.92	0.79	0.72	0.99	0.68	-0.09	-0.74	0.72	0.93		0.83	0.25	-0.63	-0.36	0.93	0.92
Common Stock Shares Outstanding	0.98	0.9	0.56	0.98	0.92	0.23	0.92	0.89	0.75	-0.79	-0.95	0.91	0.89	0.87	0.9	0.23	-0.91	0.93	0.92	0.83		0.39	-0.74	-0.52	0.93	0.93
Short Term Investments	0.39	0.32	0.4	0.4	0.48	-0.21	0.44	0.33	0.19	-0.12	-0.39	0.29	0.17	0.29	0.13	-0.2	-0.58	0.45	0.45	0.25	0.39		-0.62	-0.64	0.42	0.33
Long Term Debt Total	-0.75	-0.72	-0.41	-0.75	-0.87	-0.23	-0.84	-0.71	-0.66	0.61	0.76	-0.67	-0.65	-0.68	-0.56	-0.22	0.82	-0.78	-0.78	-0.63	-0.74	-0.62		0.94	-0.81	-0.74
Non Current Liabilities Total	-0.53	-0.45	-0.23	-0.54	-0.65	-0.21	-0.61	-0.44	-0.49	0.4	0.52	-0.45	-0.43	-0.41	-0.36	-0.2	0.64	-0.59	-0.54	-0.36	-0.52	-0.64	0.94		-0.57	-0.49
Capital Surpluse	0.92	0.98	0.57	0.92	0.99	0.16	1.0	0.98	0.84	-0.77	-0.98	0.87	0.83	0.96	0.8	0.15	-0.92	0.88	0.99	0.93	0.93	0.42	-0.81	-0.57		0.98
Inventory	0.94	0.97	0.66	0.94	0.98	0.26	0.97	0.96	0.77	-0.87	-0.96	0.92	0.91	0.95	0.83	0.26	-0.9	0.92	0.97	0.92	0.93	0.33	-0.74	-0.49	0.98

Click cells to compare fundamentals

Twist Bioscience Account Relationship Matchups

Twist Bioscience fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	398.9M	702.1M	961.4M	776.4M	892.9M	454.3M
Short Long Term Debt Total	36.0M	62.9M	94.9M	94.1M	108.2M	113.6M
Other Current Liab	2.6M	9.6M	53.5M	7.8M	9.0M	11.3M
Total Current Liabilities	36.0M	63.1M	90.7M	73.3M	84.3M	45.4M
Total Stockholder Equity	336.3M	580.8M	789.4M	623.4M	716.9M	752.8M
Other Liab	158K	351K	5.1M	60K	69K	65.6K
Net Tangible Assets	150.4M	334.8M	540.1M	789.4M	907.8M	953.2M
Property Plant And Equipment Net	59.2M	105.7M	214.4M	203.4M	233.9M	245.6M
Current Deferred Revenue	18.8M	28.8M	3.5M	36.6M	42.1M	44.2M
Net Debt	(57.7M)	(402.9M)	(283.8M)	(192.4M)	(173.2M)	(181.8M)
Retained Earnings	(458.5M)	(610.6M)	(828.4M)	(1.0B)	(929.7M)	(883.2M)
Accounts Payable	4.8M	14.9M	20.1M	14.1M	16.2M	10.5M
Cash	93.7M	465.8M	378.7M	286.5M	329.4M	194.1M
Non Current Assets Total	64.0M	155.6M	364.9M	352.1M	405.0M	425.2M
Non Currrent Assets Other	3.4M	9.2M	5.0M	8.5M	9.8M	5.2M
Other Assets	4.4M	3.4M	49.9M	(1K)	(1.2K)	(1.1K)
Cash And Short Term Investments	290.0M	477.9M	505.0M	336.4M	386.9M	267.6M
Net Receivables	26.4M	28.5M	40.3M	44.1M	50.7M	53.2M
Common Stock Shares Outstanding	39.2M	48.3M	53.9M	56.9M	65.4M	39.9M
Short Term Investments	196.3M	12.0M	126.3M	49.9M	57.4M	73.5M
Liabilities And Stockholders Equity	398.9M	702.1M	961.4M	776.4M	892.9M	454.3M
Non Current Liabilities Total	26.6M	58.2M	81.3M	79.6M	71.7M	90.3M
Capital Surpluse	470.4M	794.6M	1.2B	1.6B	1.9B	2.0B
Inventory	12.3M	31.8M	39.3M	32.1M	36.9M	38.7M
Other Current Assets	6.2M	8.3M	11.9M	11.7M	13.5M	14.1M
Other Stockholder Equity	794.6M	1.2B	1.6B	1.7B	1.9B	2.0B
Total Liab	62.6M	121.3M	172.0M	153.0M	137.7M	123.3M
Property Plant And Equipment Gross	59.2M	105.7M	214.4M	203.4M	233.9M	245.6M
Total Current Assets	334.9M	546.5M	596.5M	424.3M	487.9M	314.2M
Non Current Liabilities Other	25.2M	58.2M	60K	475K	546.3K	518.9K
Short Term Debt	9.7M	9.8M	13.6M	14.9M	17.1M	8.9M
Intangible Assets	307K	18.3M	59.7M	54.5M	62.7M	65.8M
Property Plant Equipment	20.8M	25.5M	44.1M	214.4M	246.5M	258.9M
Net Invested Capital	341.0M	1.6M	789.4M	623.4M	716.9M	752.8M

Pair Trading with Twist Bioscience

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Twist Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Twist Bioscience will appreciate offsetting losses from the drop in the long position's value.

Moving together with Twist Stock

0.77

DMAC

DiaMedica Therapeutics

Pair Corr

Moving against Twist Stock

0.57	XFOR	X4 Pharmaceuticals	Pair Corr
0.48	FLGC	Flora Growth Corp	Pair Corr
0.46	VRNA	Verona Pharma PLC	Pair Corr

The ability to find closely correlated positions to Twist Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Twist Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Twist Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Twist Bioscience Corp to buy it.

The correlation of Twist Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Twist Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Twist Bioscience Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Twist Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Twist Bioscience Corp is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Twist Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Twist Bioscience Corp Stock. Highlighted below are key reports to facilitate an investment decision about Twist Bioscience Corp Stock:

How To Invest In Twist

Details

Is Twist Stock a good investment?

Details

What is Twist Bioscience's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Twist Bioscience Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Complementary Tools for Twist Stock analysis

When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.

	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Stocks Directory Find actively traded stocks across global markets
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Bonds Directory Find actively traded corporate debentures issued by US companies

Is Twist Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Twist Bioscience. If investors know Twist will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Twist Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.36)

Revenue Per Share

4.834

Quarterly Revenue Growth

0.251

Return On Assets

(0.16)

Return On Equity

(0.30)

The market value of Twist Bioscience Corp is measured differently than its book value, which is the value of Twist that is recorded on the company's balance sheet. Investors also form their own opinion of Twist Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Twist Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Twist Bioscience's market value can be influenced by many factors that don't directly affect Twist Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Twist Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Twist Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Twist Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Twist Net Debt vs Retained Earnings Analysis

Net Debt vs Retained Earnings

Net Debt vs Retained Earnings Correlation Analysis

Correlation Coefficient

Net Debt

Retained Earnings

Twist Bioscience fundamental ratios Correlations

Twist Bioscience Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Twist Bioscience fundamental ratios Accounts

Pair Trading with Twist Bioscience

Moving together with Twist Stock

Moving against Twist Stock

Complementary Tools for Twist Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Net	+ 1.0	Short Long Term Debt Total
Other Assets	+ 1.0	Other Liab
Capital Surpluse	+ 1.0	Net Tangible Assets
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Total Current Liabilities	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Short Long Term Debt Total

Capital Surpluse	- 0.98	Retained Earnings
Net Receivables	- 0.98	Retained Earnings
Cash	- 0.97	Net Debt
Retained Earnings	- 0.97	Net Tangible Assets
Inventory	- 0.96	Retained Earnings
Retained Earnings	- 0.96	Property Plant And Equipment Net